INHANCE Stemless Reverse Shoulder IDE
Part of paid clinical trials in Irvine, California.
- Sponsor
- DePuy Orthopaedics
- Study ID
- NCT06323980
- Status
- Recruiting
Conditions
- Arthroplasty
- Replacement
- Shoulder
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Reverse Total Shoulder — DEVICEUncemented Reverse Total Shoulder
Study Details
2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market Study of the INHANCE Stemless Reverse Cementless Total Shoulder.
Key Dates
- Start date
- Mar 4, 2025
- Status verified
- Jun 2026
- Primary completion
- Nov 10, 2027
- Completion
- Oct 30, 2028
Study Design
- Enrollment
- 168 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: INHANCE Stemless ReverseINHANCE(TM) Stemless Reverse Total Shoulder
- Active Comparator: INHANCE Stemmed ReverseINHANCE(TM) Stemmed Reverse Total Shoulder
Primary Outcome Measure
Constant Murley Score (CMS) [ Time Frame: Pre-op, 2 years ]
Central Contacts
- Study Contact574-404-7996
Locations (19)
Find similar trials in Irvine, CA
By research site
Related Studies
- Reduction of Bacterial Seeding in Total Shoulder ArthroplastyRecruiting · St. Louis University · St Louis, Missouri
- Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint ArthroplastyPHASE4 · Not Yet Recruiting · Mayo Clinic · Scottsdale, Arizona